联系人：李经理
手机：18116171568
邮箱：lgj@theramabs.com
地址：上海浦东新区惠南镇东征路133号
网址：www.Theraprotein.com
Product Name：Trastuzumab |
Introduction: |
This product is the biosimilar of Trastuzumab (180288-69-1), which is a humanized IgG1 kappa monoclonal antibody that selectively binds with high affinity to the extracellular domain of the human epidermal growth factor receptor 2 protein, HER2. The biosimilar is produced by recombinant DNA technology in a mammalian cell (Chinese Hamster Ovary). *Statement: this product is used for R&D and IND only, not for clinical and commercial usage before registered in drug registration authority. |
Features and Advantages: |
| NameTrastuzumabCAS NO.180288-69-1TypeWhole antibodySourcehumanized (from mouse)TargetHER2/neuCloneMonocloneFormulaC6470H10012N1726O2013S42Molecular Weight146 kDaAntibody FormPurified immunoglobulinPhysical FormSolutionPlace of OriginUSAStorageSealed and stored at -70±15℃, away from light |
Specifications: |
The Trastuzumab is supplied at 2mg/tube, 5mg/tube, 10mg/tube, 20mg/tube as a sterile, clear and colorless, preservative-free solution. |
Quality Assurance： |
(1) We have advanced technology and equipment to satisfy the requirements of GMP. All the raw material purchasing and production quality control are strictly following the ISO9001. (2) We own a group of QCs with rich experience, mainly engaging in testing APIs, intermediates and finished products. Before posting, all of the stuffs must receive professional training and GMP courses. (3) The COA(Certificate of Analysis), MOA(Method of Analysis), SDS(Stability Data Sheet), DMF(Drug Master File) and MSDS(Material Safety Data Sheet) are available. |